Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Relapsed/Refractory DLBCL Treatment Landscape

July 17th 2020

The Role of Transplant in Multiple Myeloma

July 17th 2020

Treating Transplant-Eligible and -Ineligible MM

July 17th 2020

R/R DLBCL: Transplant Eligibility and R-CHOP

July 17th 2020

Transplant-Ineligible Multiple Myeloma

July 17th 2020

Newly Diagnosed DLBCL: Treatment Decision Factors

July 17th 2020

DLBCL Risk Assessment and Genetic Signatures

July 17th 2020

Tolerability of Triplet Therapy in Multiple Myeloma

July 17th 2020

Therapy Initiation Prior to Cytogenetic Testing Results

July 17th 2020

Frontline Triplet Therapies in Multiple Myeloma

July 17th 2020

CAR T Pioneers Describe Challenges Faced in Cancer

July 16th 2020

Advances of chimeric antigen receptor T-cell therapy technologies are in rapid development and under investigation in a range of preclinical and clinical research around the globe.

Dr. Daver on the Advancing Treatment Landscape in AML

July 16th 2020

Naval G. Daver, MD, discusses the advancing treatment landscape in both acute myeloid leukemia and acute lymphoblastic leukemia.

Dr. Daver on the Utility of Maintenance Therapy in AML

July 15th 2020

Naval G. Daver, MD, discusses the utility of maintenance chemotherapy in acute myeloid leukemia.

Closing Thoughts on Treatment of R/R DLBCL

July 15th 2020

Improving Outcomes in Patients With R/R DLBCL

July 15th 2020

Emerging Therapies for R/R DLBCL

July 15th 2020

Safety and Efficacy of Oral Agents in R/R DLBCL

July 15th 2020

Treatment of R/R DLBCL: CD19-Directed Therapy vs CAR T

July 15th 2020

CD19-Directed Therapies for Treatment of R/R DLBCL

July 15th 2020

CAR T in R/R DLBCL: Safety and Patient Selection

July 15th 2020